Article metrics

Download PDFPDF

Outcomes of vedolizumab therapy in patients with immune checkpoint inhibitor–induced colitis: a multi-center study

 

Online download statistics by month:

Online download statistics by month: December 2019 to October 2024

AbstractFullPdf
Dec 2019330
Jan 202010101
Feb 202042427
Mar 2020343410
Apr 202026265
May 202034345
Jun 202023236
Jul 202045459
Aug 2020414125
Sep 2020505030
Oct 2020585811
Nov 2020242413
Dec 2020626223
Jan 2021727233
Feb 2021545414
Mar 2021595824
Apr 2021454527
May 2021555552
Jun 2021505036
Jul 2021656531
Aug 2021464626
Sep 2021565640
Oct 2021373734
Nov 2021767653
Dec 2021606034
Jan 2022959816
Feb 2022838931
Mar 2022535819
Apr 2022596315
May 2022797919
Jun 2022798427
Jul 2022667223
Aug 20229910135
Sep 2022889434
Oct 2022727720
Nov 202211011133
Dec 2022838431
Jan 2023979724
Feb 202316816931
Mar 202310510520
Apr 2023757530
May 202310911238
Jun 2023707024
Jul 2023999929
Aug 2023959522
Sep 20239710020
Oct 202314114225
Nov 202314114133
Dec 202315015017
Jan 2024717120
Feb 2024959512
Mar 202420921240
Apr 202420720831
May 202415115128
Jun 202416316532
Jul 202417317428
Aug 2024178174136
Sep 202417817932
Oct 202419119364
Total505651131588